FDA scales back Alzheimer’s drug uses approved just a month ago
The U.S. Food and Drug Administration (FDA) scaled back its recommended uses for a controversial Alzheimer’s drug just a month after approving it for blanket use.
The U.S. Food and Drug Administration (FDA) scaled back its recommended uses for a controversial Alzheimer’s drug just a month after approving it for blanket use.